Cargando…
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants
The novel mechanisms of action (MOA) derived from some recently introduced molecular targets have led to regulatory approvals for rapid acting antidepressants (RAADs) that can generate responses within hours or days, rather than weeks or months. These novel targets include the N-methyl-D-glutamate r...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272853/ https://www.ncbi.nlm.nih.gov/pubmed/37333908 http://dx.doi.org/10.3389/fpsyt.2023.1135828 |